Abstract
The global distribution of clinical trials is grossly imbalanced to support evaluation of new treatments for prevalent cancers in developed countries with relative lack of research to improve outcome of the most lethal cancers in tropical countries. There are potential benefits in tropical countries from participating in such trials, provided the infrastructure is in place, since patients may receive treatment on trial that is not otherwise available because of cost, pharmaceutical companies benefit from rapid recruitment, and oncologists and their centres may receive financial support. However, the results of such trials can rarely be applied subsequently because the cost of new drugs is high and set by profit-driven considerations in developed countries. There is a great need for trials focussed on types of cancer that are common in tropical countries: International organisations, and the small number of wealthy countries in tropical regions, should support and lobby for infrastructure and resources to allow them to take place. Lessons can be learned from the coordinated response to the HIV epidemic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Creese A, Floyd K, Alban A, Guinness L (2002) Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 359:1635–1643
El-Sadr WM, Holmes CB, Mugyenyi P et al (2012) Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr 60(Suppl 3):S96–S104
Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150
Merson MH, O'Malley J, Serwadda D, Apisuk C (2008) The history and challenge of HIV prevention. Lancet 372:475–488
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Seruga B, Hertz PC, Le LW, Tannock IF (2010) Global drug development in cancer: a cross-sectional study of clinical trial registries. Ann Oncol 21:895–900
Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, Badwe RA (2014) Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst 106:dju009
Tas F (2008) The contribution of countries and world regions in productivity of oncological publication. Ann Oncol 19:1962–1968
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tannock, I.F., Aziz, Z. (2015). Cancer Clinical Trials in the Tropical Area. In: Droz, JP., Carme, B., Couppié, P., Nacher, M., Thiéblemont, C. (eds) Tropical Hemato-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18257-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-18257-5_9
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18256-8
Online ISBN: 978-3-319-18257-5
eBook Packages: MedicineMedicine (R0)